Carisma Therapeutics's total assets for Q3 2025 were $6.55M, an increase of 30.77% from the previous quarter. CARM total liabilities were $7.42M for the fiscal quarter, a -85.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.